Experience

Institut de recherche en immunologie et en cancérologie (IRIC)

• Deputy Director - Drug Discovery Unit

  • Apr 2014 - Present

  • Biology co-chair for drug discovery programs in collaboration with Bristol-Myers Squibb - Actively participate in decision making for project progression within multi-disciplinary teams - Provide scientific expertise on GPCR pharmacology and ligand-biased signaling - Establishment of screening platforms and mechanistic studies, using BRET-based biosensors • Direct support to the Director of the Drug Discovery Unit - Contribute to the management of operational activities and strategic orientations for a group of 40+ scientists - Recruitment of new collaborators and direct supervision of a team of five research associates • Grant writing and scientific reports for public funding agencies (CFI, FPQIS, PSVT2 and FACS) Show less



Institute for Research in Immunology and Cancer (IRIC), Université de Montréal

• Scientific Consulting, Laboratory of Dr Michel Bouvier

  • Oct 2013 - Mar 2014

  - Development and optimization of new assays for compound profiling in drug discovery programs - Reports writing and presentations to external clients - Scientific patent writing - Development and optimization of new assays for compound profiling in drug discovery programs - Reports writing and presentations to external clients - Scientific patent writing



Addex Therapeutics

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Laboratory Head, In vitro Pharmacology

  • Nov 2010 - May 2013

  - Lead in vitro biologist on 5 different allosteric modulator drug discovery programs, targeting GPCRs, RTKs and cytokine receptors - Contributed to drug discovery programs in inflammation, metabolism and CNS areas, at diffrent stages, from hit identification to IND filing - Direct manager of a team of 2 to 4 research associates - Lead in vitro biologist on 5 different allosteric modulator drug discovery programs, targeting GPCRs, RTKs and cytokine receptors - Contributed to drug discovery programs in inflammation, metabolism and CNS areas, at diffrent stages, from hit identification to IND filing - Direct manager of a team of 2 to 4 research associates



AstraZeneca R&D Montreal

• Scientist

  • Aug 2008 - Aug 2009

  - Provide technical and scientific support for the projects by developing and performing screening assays on GPCRs and ion channels - Evaluate a novel label-free technology (Epic) for lead optimization purpose - Provide technical and scientific support for the projects by developing and performing screening assays on GPCRs and ion channels - Evaluate a novel label-free technology (Epic) for lead optimization purpose